Form 4: Alphatec Holdings Executive Receives Significant RSU Grants
SEC Form 4 Filing
David Sponsel, EVP of Sales at Alphatec Holdings, was granted a total of 269,019 restricted stock units (RSUs) on January 29, 2025, with varying vesting schedules.
Summary
- David Sponsel, the EVP of Sales at Alphatec Holdings, received multiple grants of restricted stock units (RSUs) on January 29, 2025.
- The first grant was for 133,591 RSUs, awarded based on the company's performance criteria for the fiscal year ending December 31, 2024.
- These RSUs will vest in three equal installments on March 5, 2025, March 5, 2026, and March 5, 2027.
- A second grant of 114,322 RSUs was also awarded, vesting in three equal installments on March 5, 2026, March 5, 2027, and March 5, 2028.
- Additionally, 21,106 RSUs were granted in lieu of a portion of Sponsel's 2024 cash bonus, vesting on December 5, 2025.
- The total number of RSUs granted was 269,019, increasing Sponsel's direct holdings to 771,330 shares.
Sentiment
Score: 7
Explanation: The document reflects a positive event for the executive and indicates the company's commitment to incentivizing its leadership. It is a standard practice and does not indicate any negative sentiment.
Positives
- The RSU grants indicate the company's confidence in the executive's performance and future contributions.
- The vesting schedules provide an incentive for continued performance and retention of the executive.
- The grant of RSUs in lieu of cash bonus suggests a strategic approach to compensation.
Risks
- The vesting of RSUs is contingent on the executive's continued employment with the company.
- The value of the RSUs is subject to the market price of the company's stock, which can fluctuate.
Future Outlook
The document does not contain any specific forward-looking statements beyond the vesting schedules of the RSUs.
Industry Context
The granting of RSUs is a common practice in the industry to incentivize and retain key executives. This is a standard form 4 filing for a stock grant.
Comparison to Industry Standards
- RSU grants are a common form of executive compensation in the medical device industry, aligning executive interests with shareholder value.
- Companies like Medtronic and Stryker also use equity-based compensation to attract and retain talent.
- The vesting schedules are typical for RSU grants, usually over a 3-4 year period.
Stakeholder Impact
- Shareholders may view the RSU grants as a positive sign of the company's commitment to retaining key talent.
- Employees may see this as a positive sign of the company's financial health and commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date used to determine the 30-day average trading price of the issuer's common stock for the bonus RSU grant. |
| 01/29/2025 | Date of the RSU grants to David Sponsel. |
| 01/31/2025 | Date the Form 4 was signed. |
| 03/05/2025 | First vesting date for the first RSU grant. |
| 03/05/2026 | Second vesting date for the first RSU grant and first vesting date for the second RSU grant. |
| 03/05/2027 | Third vesting date for the first RSU grant and second vesting date for the second RSU grant. |
| 03/05/2028 | Third vesting date for the second RSU grant. |
| 12/05/2025 | Vesting date for the RSU grant in lieu of cash bonus. |
Keywords
RSU, Restricted Stock Units, Executive Compensation, Stock Grant, Alphatec Holdings, ATEC, David Sponsel, Vesting, Equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.